Cara Therapeutics, Inc. (CARA) Social Stream



Cara Therapeutics, Inc. (CARA): $9.36

0.25 (+2.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CARA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

CARA THERAPEUTICS INC (CARA) Price Targets From Analysts

Use the tables below to see what analysts covering CARA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 8 $35 $16 $26.125 $9.11 186.77%
2021-11-28 8 $35 $17 $26.25 $9.11 188.14%
2022-02-02 8 $35 $17.001 $26.25 $9.11 188.14%
2022-03-02 7 $35 $15 $25.875 $9.11 184.03%
2022-03-08 8 $35 $15 $26.25 $9.11 188.14%
2022-04-06 8 $33 $15 $25.5 $9.11 179.91%
2022-05-09 7 $33 $15 $25.428 $9.11 179.12%
2022-05-16 7 $33 $13 $24.571 $9.11 169.71%
2022-09-20 7 $33 $13 $24.714 $9.11 171.28%

The Trend in the Analyst Price Target


CARA's average price target has moved down $1.62 over the prior 13 months.

Over the past 45 weeks, CARA's average upside potential has been 124.81%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-09 8 35 16.000 26.125 18.14 44.02%
2021-12-21 8 35 17.001 26.250 12.29 113.59%
2022-03-02 8 35 15.000 25.875 11.53 124.41%
2022-03-08 8 35 15.000 26.250 11.71 124.17%
2022-08-15 7 33 13.000 24.714 11.75 110.33%

CARA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 6 0 1 0 0 7

The Trend in the Broker Recommendations


Over the past 14 months, CARA's average broker recommendation rating improved by 0.46.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • CARA has a higher upside potential (average analyst target price relative to current price) than 949.9% of all US stocks.
  • In the context of all US stocks, CARA THERAPEUTICS INC's variance in analysts' estimates is lower than -841.56% of them.
  • CARA has a higher average analyst price target than 375.52% of all US stocks.
  • CARA THERAPEUTICS INC's number of analysts covering the stock is higher than 1080.91% of stocks in the small market cap category.

Stocks similar to CARA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CALT, CALA, and BYSI.

Make investment decisions regarding CARA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6576 seconds.